Vaccinex Inc (VCNX) has released an update.
Vaccinex, Inc. has recently announced striking several new deals to expand access to its cutting-edge ActivMab® Antigen Virus Technology. This move could signal a significant development for the company and potentially impact its market position, making it an interesting watch for those following healthcare stocks and innovations within the financial markets.
For further insights into VCNX stock, check out TipRanks’ Stock Analysis page.
